BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1767121)

  • 1. [Wegener's granulomatosis. Therapeutic indications and follow-up course. Apropos of 5 cases].
    Urban T; Bréchot JM; Capron F; Allard P; Prudent J; Lebeau B; Rochemaure J
    Rev Mal Respir; 1991; 8(5):487-92. PubMed ID: 1767121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wegener's granulomatosis with renal involvement: a 14 year experience.
    Sizeland PC; Bailey RR; Lynn KL; Robson RA
    N Z Med J; 1990 Aug; 103(895):366-7. PubMed ID: 2385397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wegener's granulomatosis].
    Nalepa P; Niemiec A
    Pol Merkur Lekarski; 1997 Oct; 3(16):196-8. PubMed ID: 9461731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exophthalmos and cranial neuropathy as a form of presentation of Wegener's granulomatosis].
    Campello I; Sanjuán F; Brieva L; Losfablos F; Hermida I; Velilla J
    Neurologia; 1997 Apr; 12(4):168-71. PubMed ID: 9235025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A favorable result of immunosuppressive therapy combined with the use of cyclosporine in a case of particularly severe Wegener's granuloma].
    Krzemień S; Wacławik A; Hołowiecki J; Strzelczyk S
    Pol Tyg Lek; 1994 May 2-9; 49(18-19):429-32. PubMed ID: 7708573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
    Koldingsnes W; Nossent JC
    J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wegener's granulomatosis: treatment failure on conventional therapy.
    Locht H; Lindström FD
    J Rheumatol; 1989 Apr; 16(4):544-6. PubMed ID: 2746596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Wegener's granulomatosis with sulfamethoxazole-trimethoprim.
    Valeriano-Marcet J; Spiera H
    Arch Intern Med; 1991 Aug; 151(8):1649-52. PubMed ID: 1872670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients].
    Lamprecht P; Arbach O; Voswinkel J; Lilienthal T; Nölle B; Heller M; Gause A; Gross WL
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1876-80. PubMed ID: 12235553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome.
    Andrassy K; Erb A; Koderisch J; Waldherr R; Ritz E
    Clin Nephrol; 1991 Apr; 35(4):139-47. PubMed ID: 1855316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compassionate treatment of Wegener's granulomatosis with rabbit anti-thymocyte globulin.
    Hagen EC; de Keizer RJ; Andrassy K; van Boven WP; Bruijn JA; van Es LA; van der Woude FJ
    Clin Nephrol; 1995 Jun; 43(6):351-9. PubMed ID: 7554518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infectious aspects of Wegener's granulomatosis].
    Rusterholz D; Schlegel C
    Schweiz Med Wochenschr; 2000; Suppl 125():41S-43S. PubMed ID: 11141937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.
    Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L;
    Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term observations of Wegener's disease. Results of treating recurrences].
    Bohn T; Hunstein W; Ho AD
    Dtsch Med Wochenschr; 1985 Apr; 110(16):642-4. PubMed ID: 3987524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory failure in Wegener's granulomatosis: response to pulse intravenous methylprednisolone and cyclophosphamide.
    Chapman PT; O'Donnell JL
    J Rheumatol; 1993 Mar; 20(3):504-6. PubMed ID: 8478858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
    Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
    Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infliximab in the treatment of Wegener's granulomatosis: case report].
    Svozílková P; Ríhová E; Brichová M; Diblík P; Kuthan P; Poch T
    Cesk Slov Oftalmol; 2006 Jul; 62(4):280-6. PubMed ID: 16895062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.